125 related articles for article (PubMed ID: 9076645)
1. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
[TBL] [Abstract][Full Text] [Related]
2. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy.
Pearce J; Hawton K; Blake F
Br J Psychiatry; 1995 Aug; 167(2):163-73. PubMed ID: 7582665
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy subcutaneous implants for refractory menopause symptoms; the patient's perspective.
Dixit A; Carden N; Stephens E; Chadwick M; Tamblyn J; Robinson L
Post Reprod Health; 2022 Jun; 28(2):79-91. PubMed ID: 35599571
[TBL] [Abstract][Full Text] [Related]
4. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
6. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric.
Montgomery JC; Appleby L; Brincat M; Versi E; Tapp A; Fenwick PB; Studd JW
Lancet; 1987 Feb; 1(8528):297-9. PubMed ID: 2880114
[TBL] [Abstract][Full Text] [Related]
7. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
8. [The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
Yazici K; Pata O; Yazici A; Aktaş A; Tot S; Kanik A
Turk Psikiyatri Derg; 2003; 14(2):101-5. PubMed ID: 12844276
[TBL] [Abstract][Full Text] [Related]
9. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
Masuda Y; Hirao T; Mizunuma H
J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
[TBL] [Abstract][Full Text] [Related]
10. [Effects of estrogen supplementation on psychological variables in climacteric women].
Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
[TBL] [Abstract][Full Text] [Related]
11. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
12. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
[TBL] [Abstract][Full Text] [Related]
13. A community-based study of menopause symptoms and estrogen replacement in older women.
von Mühlen DG; Kritz-Silverstein D; Barrett-Connor E
Maturitas; 1995 Sep; 22(2):71-8. PubMed ID: 8538487
[TBL] [Abstract][Full Text] [Related]
14. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy.
Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
Psychoneuroendocrinology; 1997 Oct; 22(7):549-58. PubMed ID: 9373888
[TBL] [Abstract][Full Text] [Related]
15. Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants.
File SE; Heard JE; Rymer J
Psychopharmacology (Berl); 2002 Apr; 161(1):107-12. PubMed ID: 11967638
[TBL] [Abstract][Full Text] [Related]
16. Why do postmenopausal women discontinue hormone replacement therapy?
Vihtamäki T; Savilahti R; Tuimala R
Maturitas; 1999 Oct; 33(2):99-105. PubMed ID: 10597873
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
[TBL] [Abstract][Full Text] [Related]
19. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
20. Hormone implants and tachyphylaxis.
Garnett T; Studd JW; Henderson A; Watson N; Savvas M; Leather A
Br J Obstet Gynaecol; 1990 Oct; 97(10):917-21. PubMed ID: 2223683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
